Prognostic implication of elevated cardiac troponin I in patients visiting emergency department without diagnosis of coronary artery disease
Authors:
- 14 January 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 59 (6) , 1107-1113
Abstract
Objectives: Elevated cardiac troponin is not uncommon in patients visiting emergency department (ED) even without coronary artery disease, but its prognostic implication is not well understood in such patients. Methods: In this retrospective single-center registry, we investigated clinical outcome of patients visiting ED without documented coronary artery disease. Patients were categorized according to the maximal value of Siemens ADVIA Centaur TnI-Ultra assay (TnI) within 24 h after visit. Primary endpoint was 180-day all-cause death that included cardiac and non-cardiac death. Results: A total of 35,205 patients with median age 61 years and male gender 54.7% were included. Below the lowest level of detection (LOD) (≤0.006 ng/mL), between LOD and assay-specific <99th percentile (0.007–0.039 ng/mL), below median of ≥99th percentile (0.040–0.149 ng/mL), and above median of ≥99th percentile (≥0.150 ng/mL) TnI were found in 18,502 (52.6%), 11,338 (32.2%), 3,029 (8.6%), and 2,336 (6.6%) patients. In the 180-day follow-up period, 4,341 (12.3%) all-cause death including 694 (2.0%) cardiovascular death and 3,647 (10.4%) non-cardiovascular death developed. The risks of all-cause, cardiovascular, and non-cardiovascular death increased across higher TnI strata (hazard ratio [HR]=1.3 to 2.4; 2.0 to 9.3; 1.3 to 1.7; p<0.001, all). Analyses of multivariate models showed consistent results. Conclusions: In patients visiting ED, elevated TnI was associated with higher risk of 180-day cardiovascular and non-cardiovascular death. Patients with elevated TnI may need additional evaluation or careful follow-up even without primary diagnosis of coronary artery disease.Keywords
Funding Information
- Ministry of Trade Industry & Energy, Ministry of Science & ICT, Ministry of Health and Welfare under Technology Development Program for Ai-Bio-Robot-Medicine Convergence (20001704)
- National Research Foundation of Korea (2017R1A2B310918)
This publication has 18 references indexed in Scilit:
- Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort studyBMJ, 2017
- Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC studyEuropean Journal of Preventive Cardiology, 2016
- A National Study of the Prevalence of Life-Threatening Diagnoses in Patients With Chest PainJAMA Internal Medicine, 2016
- Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortiumEuropean Heart Journal, 2016
- Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency departmentEuropean Heart Journal, 2016
- High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort studyThe Lancet, 2015
- Troponin Elevation in Patients Without Acute Coronary SyndromeRevista Española de Cardiología (English Edition), 2015
- High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort studyBMJ, 2015
- Cardiac troponin level elevations not related to acute coronary syndromesNature Reviews Cardiology, 2013
- High Sensitivity Troponin in Chest Pain and Acute Coronary Syndromes. A Step Forward?Revista Española de Cardiología (English Edition), 2010